Jesus Jimenez, MD, PhD, has been appointed as the Director for Diversity, Equity, and Inclusion for Fellows and Postdoctoral trainees in the Department of Medicine. Dr. Jimenez grew up in southern California and completed his undergraduate degree in Molecular Biology at the University of California, San Diego. He joined the Medical Scientist Training Program and received […]
The cardiovascular division is hosting the tenth annual Cardiovascular Research Day this Thursday, October 13th! Join us for posters, presentations, and lectures celebrating basic, clinical and translational cardiovascular research at Washington University.
As part of the Apollo clinical trial, a team of Wash U physicians successfully completed a transseptal transcatheter mitral valve replacement at Barnes-Jewish Hospital. Washington University is the only participating Missouri location for the trial. The surgical team included the Cardiovascular Division’s Dr. Alan Zajarias, Dr. Marc Sintek, Dr. Majesh Makan, and Dr. Sam Lindner […]
On November 11, 2022 the Washington University School of Medicine Cardiovascular Division will be celebrating our 75th Anniversary! You won’t want to miss this event, which will include guest speakers, panels with current and former faculty and fellows, and more. The celebration will take place at the Eric P. Newman Education Center on the Medical […]
Join faculty members in the Divisions of Cardiothoracic Surgery and Cardiology at Washington University School of Medicine as they unite with Northwestern University Feinberg School of Medicine and Ascension St. Vincent Heart Center of Indiana for the 4th Annual Heart Team Summit.
This event will begin on Friday, October 21, and conclude on Saturday, October 22, at the Four Seasons Hotel (999 N 2nd St) in St. Louis.
Cardiovascular division faculty members Karen Joynt Maddox (co-Director, Center for Health Economics & Policy) and Gmerice Hammond (Associate Director, Center for the Study of Race, Ethnicity & Equity) along with their colleagues at the Institute of Public Health will be hosting a seminar October 19th entitield Algorithms of Oppression, presented by Dr. Safiya U. Noble.
Kory Lavine, MD, PhD, received the International Society for Heart Research- North American Section 2022 MCI Leadership Achievement Award, presented in Winnipeg, Manitoba, Canada at the section’s annual meeting on September 6th.
Three faculty from the Brown School and the School of Medicine at Washington University in St. Louis have received a seven-year $6.1 million grant from the National Institutes of Health (NIH) aimed at improving the health of mothers and children in the St. Louis region. The project, titled “Enhancing Cardiovascular Health Equity in Mothers and […]
Among men diagnosed with COVID-19, those with low testosterone levels are more likely to become seriously ill and end up in the hospital than men with normal levels of the hormone, according to a study by researchers at Washington University School of Medicine in St. Louis and Saint Louis University School of Medicine.
The team analyzed the cases of 723 men who tested positive for COVID-19, mostly in 2020 before vaccines were available. The data indicate that low testosterone is an independent risk factor for COVID-19 hospitalization, similar to diabetes, heart disease and chronic lung disease.
Stacey Rentschler, MD, PhD in collaboration with many other Washington University researchers within and outside the cardiovascular division recently received an NIH grant totaling over $3 million to further study a major breakthrough in a non-invasive treatment for ventricular tachycardia. The grant follows a 2021clinical study from Washington University School of Medicine brought together cardiologists, […]
A new study published in the Journal of Electrocardiology this month by Washington University Physician Adam May shows that an automated tool for WCT differentiation can improve the accuracy of the physician interpreting ECGs.
Dr. Alan Zajarias and the team at the Valvular Heart Disease Center have been invited to join the Edwards Triscend 2 pivotal trial, testing the safety and effectiveness of the Evoque valve device in patients with tricuspid regurgitation. The Evoque tricuspid valve replacement system is designed to use an implant to replace the native tricuspid […]
An estimated 1,000,000 people in the U.S. have hypertrophic cardiomyopathy. Washington University interventional cardiologist Richard Bach, MD, FACC, and his team had exhausted non-invasive treatments for a patient suffering from HCM. Until, that is, Bach enrolled the man, who was in his 50s, in a clinical trial evaluating a drug called mavacamten.